scholarly journals Transdermal Fentanyl patch: An approach to enhance tolerance of conscious proning in COVID-19 patients

2020 ◽  
Vol 16 (4) ◽  
pp. 237-238
Author(s):  
Sowmia Mammen, MBBS, DNB ◽  
Beena Yousuf, MBBS, FCPS ◽  
Mohammad Shamsah, MBBS, FRCPC

The COVID-19 ARDS appears to have worse outcomes than ARDS from other causes. It is a predictable serious complication and the key strategy is to maintain oxygenation. Adopting the prone position for conscious COVID-19 patients requiring basic respiratory support, is shown to benefit patients in terms of improving oxygenation, reducing the need for invasive ventilation and potentially even reducing mortality. Cough and myalgia are the common and most distressing symptoms seen in conscious COVID-19 patients which can impair tolerance to awake proning. Modified awake proning with application of transdermal fentanyl patch (TFP) can improve the compliance to conscious proning in COVID-19 patients.

1996 ◽  
Vol 32 (1) ◽  
pp. 19-24 ◽  
Author(s):  
M Scherk-Nixon

A transdermal therapeutic system (TTS) has been developed for the continuous delivery of fentanyl citrate to provide ongoing analgesia in human patients with chronic pain. Several researchers believe that fentanyl transdermal patches have a place in postoperative pain control. The purpose of this study was to determine whether transdermal technology is an effective way of administering fentanyl to feline patients. Fentanyl patches were applied to the skin of six cats, and blood samples for fentanyl analysis were collected over 104 hours. This study establishes that the transdermal patch technology is an effective, long-lasting, cost-effective, noninvasive, and well-tolerated mode of deliverying fentanyl to cats.


1998 ◽  
Vol 27 (2) ◽  
pp. 159-166 ◽  
Author(s):  
CHRISTINE M. EGGER ◽  
TANYA DUKE ◽  
JOY ARCHER ◽  
PETER H. CRIBB

Sign in / Sign up

Export Citation Format

Share Document